Predictive Laboratories, a wholly owned molecular and genetic diagnostics company of Predictive Technology Group (OTC Pink: PRED), is focused on hard-to-detect diseases. The laboratory is equipped with state-of-the-art equipment for next-generation sequencing experiments including whole exosome sequencing, gene and genetic marker panels, and low-pass whole genome analysis of embryos for aneuploidies.
Certifications:
- Clinical Laboratory Improvement Amendments of 1988 (CLIA), to perform high complexity testing
- Accredited by the College of American Pathologists (CAP) in Molecular Pathology